Jul 17
Health Highlights: July 16, 2010 - BusinessWeek
|
Health Highlights: July 16, 2010
BusinessWeek The application for Qnexa was submitted by Mountainview, Calif., drugmaker Vivus Inc. The agency has not approved a new prescription weight loss pill in … |
Product Recalls: Slim-30 Herb Supplement - The Associated Press
|
Product Recalls: Slim-30 Herb Supplement
The Associated Press The product, marketed as a natural herb for weight loss, was sold to distributors and retail stores nationwide and in China as well as online. … J & H Besta Corp. Issues a Voluntary Nationwide Recall of Slim- 30 Herb … |
Vivus Plunges Most Ever After US Review of Qnexa - BusinessWeek
 CBS News |
Vivus Plunges Most Ever After US Review of Qnexa
BusinessWeek “Weight loss is a long-term concern and therefore if someone is arguably going to be taking a drug for a long time you need to have long-term safety studies … Vivus Weight-Loss Drug Qnexa Rejected Weight-loss drug Qnexa gets thumbs-down from FDA panel FDA Panel Rejects Vivus Obesity Pill Qnexa |
BEFORE THE BELL: US Stock Futures Higher As GE, BAC Top Estimates - Wall Street Journal
|
BEFORE THE BELL: US Stock Futures Higher As GE, BAC Top Estimates
Wall Street Journal The Food and Drug Administration rejected Vivus Inc.'s (VVUS) weight-loss drug Qnexa, sending down shares of rival weight-loss-drug makers Arena … |
Locally Made Diet Pill Closer to Approval - NBC San Diego
 ColdBee (blog) |
Locally Made Diet Pill Closer to Approval
NBC San Diego AP The weight-loss pill made by Arena Pharmaceuticals passed a major milestone by being featured in the "New England Journal of Medicine. … Expect FDA drug approval & weight loss: New fen-phen type diet pill Lorcaserin … Lorcaserin Diet Pill: New Diet Pill Seems Promising Arena's Lorcaserin Helped Overweight Adults Lose More Weight |
CORRECT: US HOT STOCKS: Goldman Sachs, Google, BP Active In Late Trading - Wall Street Journal
|
CORRECT: US HOT STOCKS: Goldman Sachs, Google, BP Active In Late Trading
Wall Street Journal A US Food and Drug Administration panel rejected Vivus Inc.'s (VVUS) weight-loss drug Qnexa, sending down shares of rival weight-loss drug makers Arena … |
Weight Loss Supplements Bomb in Major Studies - Diet Blog (blog)
 TopNews Arab Emirates |
Weight Loss Supplements Bomb in Major Studies
Diet Blog (blog) Average weight loss was between 1 kg and 2 kg across seven of the products, depending on the supplement, and was 1.2 kg in the group getting the placebo … Study Casts Doubt on Weight Loss Supplements Ingredients in Weight Loss Vitamins Prove to be Ineffective Study: Popular Drugstore Slimming Supplements Do Nothing to Boost Weight Loss |
Consumers Often a Target for Miracle Health Claims - eMaxHealth
 Reuters India |
Consumers Often a Target for Miracle Health Claims
eMaxHealth Text that uses impressive-sounding terms like these for a weight-loss product: "hunger stimulation point" and "thermogenesis." • Undocumented case histories … Nestle, Iovate Settle with FTC Nestles to Quit Making “Boost” Claims Nestle, supplement co. settle federal ad cases |
Health Highlights: July 16, 2010 - BusinessWeek
|
Health Highlights: July 16, 2010
BusinessWeek The application for Qnexa was submitted by Mountainview, Calif., drugmaker Vivus Inc. The agency has not approved a new prescription weight loss pill in … |
Product Recalls: Slim-30 Herb Supplement - The Associated Press
|
Product Recalls: Slim-30 Herb Supplement
The Associated Press The product, marketed as a natural herb for weight loss, was sold to distributors and retail stores nationwide and in China as well as online. … J & H Besta Corp. Issues a Voluntary Nationwide Recall of Slim- 30 Herb … |
Vivus Plunges Most Ever After US Review of Qnexa - BusinessWeek
CBS News |
Vivus Plunges Most Ever After US Review of Qnexa
BusinessWeek “Weight loss is a long-term concern and therefore if someone is arguably going to be taking a drug for a long time you need to have long-term safety studies … Vivus Weight-Loss Drug Qnexa Rejected Weight-loss drug Qnexa gets thumbs-down from FDA panel FDA Panel Rejects Vivus Obesity Pill Qnexa |
BEFORE THE BELL: US Stock Futures Higher As GE, BAC Top Estimates - Wall Street Journal
|
BEFORE THE BELL: US Stock Futures Higher As GE, BAC Top Estimates
Wall Street Journal The Food and Drug Administration rejected Vivus Inc.'s (VVUS) weight-loss drug Qnexa, sending down shares of rival weight-loss-drug makers Arena … |
Locally Made Diet Pill Closer to Approval - NBC San Diego
ColdBee (blog) |
Locally Made Diet Pill Closer to Approval
NBC San Diego AP The weight-loss pill made by Arena Pharmaceuticals passed a major milestone by being featured in the "New England Journal of Medicine. … Expect FDA drug approval & weight loss: New fen-phen type diet pill Lorcaserin … Lorcaserin Diet Pill: New Diet Pill Seems Promising Arena's Lorcaserin Helped Overweight Adults Lose More Weight |
CORRECT: US HOT STOCKS: Goldman Sachs, Google, BP Active In Late Trading - Wall Street Journal
|
CORRECT: US HOT STOCKS: Goldman Sachs, Google, BP Active In Late Trading
Wall Street Journal A US Food and Drug Administration panel rejected Vivus Inc.'s (VVUS) weight-loss drug Qnexa, sending down shares of rival weight-loss drug makers Arena … |
Weight Loss Supplements Bomb in Major Studies - Diet Blog (blog)
TopNews Arab Emirates |
Weight Loss Supplements Bomb in Major Studies
Diet Blog (blog) Average weight loss was between 1 kg and 2 kg across seven of the products, depending on the supplement, and was 1.2 kg in the group getting the placebo … Study Casts Doubt on Weight Loss Supplements Ingredients in Weight Loss Vitamins Prove to be Ineffective Study: Popular Drugstore Slimming Supplements Do Nothing to Boost Weight Loss |
Consumers Often a Target for Miracle Health Claims - eMaxHealth
Reuters India |
Consumers Often a Target for Miracle Health Claims
eMaxHealth Text that uses impressive-sounding terms like these for a weight-loss product: "hunger stimulation point" and "thermogenesis." • Undocumented case histories … Nestle, Iovate Settle with FTC Nestles to Quit Making “Boost” Claims Nestle, supplement co. settle federal ad cases |